Vaccination has proved relatively unsuccessful against the common mammalian commensal
bacteria Staphylococcus, despite almost a century of experimentation. Recent progress in
clinical trials, animal models and molecular laboratories offers hope that these organisms
might be partially or wholly controlled by augmenting host responses.